Elevated maternal serum alpha-fetoprotein with low unconjugated estriol and the risk for lethal perinatal outcome

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 9, Issue 3, 2000, Pages 165-169

  Benn, Peter A ^a   Craffey, Alicia ^a   Horne, Donna ^a   Ramsdell, Lisa ^a   Rodis, John F ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Chromosome abnormalities; Fetal death; Neural tube defects; Prenatal screening

Indexed keywords

ALPHA FETOPROTEIN; ESTRIOL;

ADULT; ANENCEPHALUS; ARTICLE; CHROMOSOME ABERRATION; DATA ANALYSIS; DISEASE ASSOCIATION; ENCEPHALOCELE; FEMALE; FETUS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MASS SCREENING; NEURAL TUBE DEFECT; PERINATAL MORBIDITY; PRIORITY JOURNAL; RISK ASSESSMENT; SMALL FOR DATE INFANT; SPINA BIFIDA;

ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; DATABASES, FACTUAL; ESTRIOL; FEMALE; FETAL DEATH; HUMANS; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0033948697     PISSN: 14767058     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Knight GJ, Palomaki GE. Maternal serum alpha-fetoprotein and the detection of open neural tube defects. In: Elias S, Simpson JL, editors. Maternal serum screening for fetal genetic disorders. New York: Churchill-Livingstone; 1990. p 41-58.
2. Thomas RL, Blakemore KJ. Evaluation of elevation in maternal serum alpha-fetoprotein: a review. Obstet Gynecol Surv 1990;45:269-283.
3. Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard T, Haddow JE, Knight GJ, Palomaki GE, Canick JA. Maternal serum screening for Down's syndrome in early pregnancy. Br Med J 1988; 297:883-887.
4. Canick JA, Palomaki GE, Osthanondh R. Prenatal screening for trisomy 18 in the second trimester. Prenat Diagn 1990;10:546-548.
5. Canick JA, Knight GJ, Palomaki GE, Haddow JE. Second trimester levels of maternal serum unconjugated oestriol and human chorionic gonadotropin in pregnancies affected by fetal anencephaly and open spina bifida. Prenat Diagn 1990;10:733-737.
6. Kostiuk EV, Zolotukhina TV, Kuznetsov MI. Second trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin and unconjugated oestriol levels for some congenital malformations. Genetica 1992;28:158-162.
7. Yaron Y, Hamly DD, O'Brien JE, Critchfield G, Leon J, Ayoub M, Johnson MP, Evans MI. Combination of elevated maternal serum alpha-fetoprotein (MSAFP) and low estriol is highly predictive of anencephaly. Am J Med Genet 1998;75:297-299.
8. MacDonald PC, Siiteri PK. Origin of estrogen in women pregnant with an anencephalic fetus. J Clin Invest 1965;44:465-474.
9. Tulchinsky D, Osathanondh R, Belisle S, Ryan KL. Plasma estrone, estradiol, estriol, and their precursors in pregnancies with anencephalic fetuses. J Clin Endocrin Metab 1997;45:1100-1103.
10. Walters CP, McKinnon WC. Elevated maternal serum alpha-fetoprotein, very low unconjugated oestriol, and very low human chorionic gonadotropin associated with recent fetal death. Prenat Diagn 1993; 13:423-426.
11. Pergament E, Stein AK, Fiddler M, Cho NH, Kupferminc MJ. Adverse pregnancy outcome after a false-positive screen for Down syndrome using multiple markers. Obstet Gynecol 1995;86:255-258.
12. Kowalczyk TD, Cabaniss ML, Cusmano L. Association of low unconjugated estriol in the second trimester and adverse outcome. Obstet Gynecol 1998;91:396-400.
13. Glass IA, Lam RC, Chang T, Roitman E, Shapiro LJ, Shackleton CHL. Steroid sulphatase deficiency is the major cause of extremely low oestriol production at mid-pregnancy: a urinary steroid assay for the discrimination of steroid sulphatase deficiency from other causes. Prenat Diagn 1998;18:789-800.
14. Benn PA, Horne D, Briganti S, Greenstein RM. Prenatal diagnosis of diverse chromosome abnormalities in a population of patients identified by triple marker testing as screen positive for Down syndrome. Am J Obstet Gynecol 1995;173:496-501.
15. Benn PA, Borgida A, Horne D, Briganti S, Collins R, Rodis JF. Down syndrome and neural tube defect screening: the value of using gestational age by ultrasonography. Am J Obstet Gynecol 1997;176:1056-1061.
16. Williams RL, Creasy RK, Cunningham GC, Hawes WE, Norris FD, Tashiro M. Fetal growth and perinatal viability in California. Obstet Gynecol 1982;59:624-632.
17. Nelson LH, Bensen J, Burton BK. Outcomes in patients with unusually high maternal serum α-fetoprotein levels. Am J Obstet Gynecol 1987;157:572-576.
18. Milunsky A, Jick S, Bruell CL, MacLaughlin DS, Tsung Y-K, Jick H, Rothman KJ, Willlett W. Predictive values, relative risks, and overall benefits of high and low maternal serum α-fetoprotein screening in singleton pregnancies: new epidemiologic data. Am J Obstet Gynecol 1989;161:291-297.
19. Burton BK. Outcome of pregnancy in patients with unexplained elevated or low levels of maternal serum alpha-fetoprotein. Obstet Gynecol 1988;72:709-713.
20. Robinson L, Grau P, Crandell BF. Pregnancy outcomes after increasing maternal serum alphafetoprotein levels. Obstet Gynecol 1989;74: 17-20.
21. Bradley LA, Canick JA, Palomaki GE, Haddow JE. Undetectable maternal serum unconjugated estriol levels in the second trimester: risk of perinatal complications associated with placental sulfatase deficiency. Am J Obstet Gynecol 1997;176:531-535.
22. Bradley LA, Palomaki GE, Knight GJ, Haddow JE, Opitz JM, Irons M, Kelley RI, Tint GS. Levels of unconjugated estriol and other maternal serum markers in pregnancies with Smith-Lemli-Opitz (RSH) syndrome fetuses. Am J Med Genet 1999;82:355-358.